Orion Oyj ORNBV

HEL: ORNBV | ISIN: FI0009014377 12/11/2026

102,70 EUR (-0,10%)

(-0,10%) 12/11/2026

Grafiek Orion Oyj

Grafiek Orion Oyj

1 dag1d -0,10%
1 week1w 0,49%
1 maand1m 19,49%
3 maanden3m 32,69%
6 maanden6m 50,92%
1 jaar1j 71,17%
5 jaar5j 169,27%

Orion Oyj in het nieuws

Toon enkel gratis nieuws

28 oktober 2026 · Orion Group Interim report January–September 2026: Strong financial performance and positive developments in the R&D pipeline · Persbericht

26 oktober 2026 · Changes in Orion Group’s Executive Team as of 1 January 2027 · Persbericht

24 oktober 2026 · Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence · Persbericht

20 oktober 2026 · Inside information: Orion upgrades full-year outlook for 2026 · Persbericht

14 oktober 2026 · Orion publishes Interim Report for January–September 2026 and holds a webcast on 28 October 2026 · Persbericht

7 oktober 2026 · 125,000 Orion Corporation A shares converted into B shares · Persbericht

6 oktober 2026 · Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market · Persbericht

5 oktober 2026 · Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing · Persbericht

30 september 2026 · Orion Corporation completed share acquisitions · Persbericht

30 september 2026 · Orion Corporation: Acquisition of own shares during week 40, 2026 · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe